Skip to content
Home/Companies/Biotech/Sibylla Biotech
SB

Sibylla Biotech

Biotech·Italy·Active·4yr hold

Sibylla Biotech is a biotech company, headquartered in Italy.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Sibylla Biotech?

Sibylla Biotech is currently owned by Indaco Venture Partners SGR through Indaco BIO (2022 vintage), since 2022. Across its history, Sibylla Biotech has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-23

Indaco Venture Partners SGR
Most recent investor
Indaco Venture Partners SGR
Indaco BIO · 2022 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQItaly
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Vertis SGR and Indaco Venture Partners SGR since 2019.
Co-invest · 2 holders · 2019 · present
Vertis SGR
Vertis SGRActive
2019 · present · Vertis Venture 3 Technology Transfer · 2019 · VC
MOIC
–
Indaco Venture Partners SGR
Indaco Venture Partners SGRActive
2022 · present · Indaco BIO · 2022 · Life Sciences VC
MOIC
–

More from Indaco BIO

Other portfolio companies in the same fund.

IAMA Therapeutics
Active
BiotechItaly· 2025
Tes Pharma
Active
PharmaItaly· 2025
Valo Therapeutics
Active
BiotechFinland· 2025
Genespire
Active
BiotechItaly· 2024
Micthera
Active
BiotechItaly· 2024
Freya Biosciences
Active
BiotechDenmark· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings